Results 201 to 210 of about 117,898 (292)

Two novel imatinib‐responsive PDGFRA fusion genes in chronic eosinophilic leukaemia [PDF]

, 2007
Claire Curtis, Francis Grand, Pellegrino Musto, Andrew Clark, John Murphy, Gianni Perla, Maria Marta Minervini, Janet Stewart, Andreas Reiter, Nicholas C.P. Cross   +9 more
openalex   +1 more source

Resolution of Persistent Fever and Systemic Inflammation in a Metastatic Gastrointestinal Stromal Tumour (GIST) With Imatinib. [PDF]

Cureus
Akter S, Gaznavee KSMZZ, Rabbani R, Rahman SS, Boussios S.   +4 more
europepmc   +1 more source

Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]

, 2008
Jimenez, Sergio A., Rosenbloom, Joel
core   +1 more source

[Artículo traducido] Hiperpigmentación del paladar duro: el resultado del uso de imatinib a largo plazo

Fátima Mayo‐Martínez, Celia Requena, B Llombart   +2 more
openalex   +1 more source

Stroma-driven horizontal transfer of TCA-related proteins mediates metabolic plasticity and imatinib resistance in chronic myeloid leukemia. [PDF]

Cell Commun Signal
Chroscicki P, Kasak N, Dymkowska D, Turos-Korgul L, Cysewski D, Chumak V, Stepnik D, Kusio-Kobialka M, Kominek A, Lebiedzinska-Arciszewska M, Krop A, Szczepanowska J, Wieckowski M, Stoklosa T, Zablocki K, Piwocka K.   +15 more
europepmc   +1 more source

Effects of imatinib mesylate on spontaneous electrical and mechanical activity in smooth muscle of the guinea‐pig stomach [PDF]

, 2008
Hikaru Hashitani, Masa Hayase, Hajime Suzuki   +2 more
openalex   +1 more source

Chemical synthesis, bioinformatics and antiproliferative studies of novel pyrimidin-4-yl-1H-pyrazole derivatives in chronic myeloid cancer cells. [PDF]

Sci Rep
Rajasheker KV, Pallavi MS, Arun PC, Stupin V, Iqbal M, Roma-Rodrigues C, Baptista PV, Fernandes AR, Silina E, Kollur SP.   +9 more
europepmc   +1 more source

The Mechanisms of Imatinib Resistance in Gastrointestinal Stromal Tumours: Theoretical Basis and Therapeutic Aspect. [PDF]

J Cell Mol Med
Abudurexiti N, Lou Y, Wu M, Huang Y, Huang S, Guo K, Zheng S.   +6 more
europepmc   +1 more source

Insights into Treatment-Free Remission (TFR) outcomes in Chronic Myeloid Leukaemia (CML) - a tertiary centre experience in Malaysia. [PDF]

Blood Res
Liam CCK, Boo YL, Lim LM, Chong SL, Sharif A, Wong YS, Selvaratnam V, Tan SM, Lim SM.   +8 more
europepmc   +1 more source

Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval [PDF]

, 2018
Chalmers, Iain, Djulbegovic, Benjamin, Glasziou, Paul, Ioannidis, John P A, Klocksieben, Farina A, Mhaskar, Rahul, Reljic, Tea, VanDenBergh, Magali   +7 more
core   +1 more source